SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (523)12/3/2001 12:40:46 PM
From: tuck  Read Replies (1) | Respond to of 1005
 
BLUE HP cashes in its BDAL short at $16.30. Will simply add cash back less roundtrip commissions. BLUE HP will buy 200 shares more than it sold & look to go longer on further weakness.

All per announced plan. What a cash cow BDAL has been for BLUE HP!

Edit: BLUE HP now profitable by a hair. Hooray!

Cheers, Tuck



To: tuck who wrote (523)12/4/2001 1:53:36 PM
From: tuck  Read Replies (1) | Respond to of 1005
 
Anybody qualified want to comment on INGN's 241 PI data in the FDA link referenced in the post below? Il sembler bon a moi, mais je sais un tres peu.

Message 16744097

With GNVC getting priced like INGN for less developed work, I'm tempted by INGN again.

Cheers, Tuck